Open Access Open Access  Restricted Access Subscription or Fee Access

The misuse of prescription pain medication and borderline personality symptomatology

Randy A. Sansone, MD, Daron A. Watts, MD, Michael W. Wiederman, PhD

Abstract


Objective: Despite the known high rates of substance misuse among individuals with borderline personality disorder (BPD), little empirical data are available regarding the explicit nature of such misuse with prescribed pain medications–the focus of the present study.

Setting: A primary care outpatient setting, with predominantly resident providers, in a midsized mid-western US city.

Patients: Consecutive outpatients who currently or have previously been prescribed pain medication (ie, lifetime pain medication exposure) (n = 185).

Main outcome measures: Relationships between BPD, according to two measures, and eight author-developed items reflecting prescription pain medication misuse.

Results: With the exception of requesting a prescription for pain medication but not having pain (n.s.), all other measures of prescription pain medication misuse were statistically significantly associated with BPD symptoms. There were also some statistically significant interactions between male gender and BPD symptoms in the prediction of pain medication misuse (ie, mixing prescribed pain medications with drugs to get high, using prescribed pain medication for recreational purposes, and selling prescribed pain medications for money).

Conclusions: Individuals with BPD are at risk for misusing prescribed pain medications, and this is especially evident regarding particular forms of misuse among men with BPD symptomatology.


Keywords


borderline personality, borderline personality disorder, medication misuse, pain, pain medication, Self-Harm Inventory, substance misuse

Full Text:

PDF

References


American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: Author, 1994.

Grant BF, Chou SP, Goldstein RB, et al.: Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008; 69: 533-545.

Sansone RA, Sansone LA: Substance use disorders and borderline personality: Common bedfellows. Innov Clin Neurosci. 2011; 8(9): 10-13.

Hyler SE: Personality Diagnostic Questionniare-4. New York: Author, 1994.

Sansone RA, Wiederman MW, Sansone LA: The Self-Harm Inventory (SHI): Development of a scale for identifying self-destructive behaviors and borderline personality disorder. J Clin Psychol. 1998; 54: 973-983.

Dubro AF, Wetzler S, Kahn MW: A comparison of three self-report questionnaires for the diagnosis of DSM-III personality disorders. J Pers Disord. 1988; 2: 256-266.

Hyler SE, Lyons M, Rieder RO, et al.: The factor structure of self-report DSM-III Axis II symptoms and their relationship to clinicians’ ratings. Am J Psychiatry. 1990; 147: 751-757.

Johnson JG, Bornstein RF: Utility of the Personality Diagnostic Questionnaire-Revised in a nonclinical sample. J Pers Disord. 1992; 6: 450-457.

Patrick J, Links P, Van Reekum R, et al.: Using the PDQ-R BPD scale as a brief screening measure in the differential diagnosis of personality disorder. J Pers Disord. 1995; 9: 266-274.

Kolb JE, Gunderson JG: Diagnosing borderline patients with a semi-structured interview. Arch Gen Psychiatry. 1980; 37: 37-41.




DOI: https://doi.org/10.5055/jom.2013.0169

Refbacks

  • There are currently no refbacks.